Table of Contents Author Guidelines Submit a Manuscript
Journal of Ophthalmology
Volume 2011 (2011), Article ID 405724, 8 pages
http://dx.doi.org/10.1155/2011/405724
Clinical Study

One-Year Outcomes Using Ranibizumab for Neovascular Age-Related Macular Degeneration: Results of a Prospective and Retrospective Observational Multicentre Study

1St. Erik's Eye Hospital, Karolinska Institutet, Polhemsgatan 50, 11282 Stockholm, Sweden
2Department of Ophthalmology, Lund University Hospital, 22185 Lund, Sweden
3Department of Ophthalmology, Helsingborg Hospital, 25187 Helsingborg, Sweden
4Department of Ophthalmology, Ryhov Hospital, 55185 Jönköping, Sweden
5Department of Ophthalmology, Södersjukhuset, 11883 Stockholm, Sweden
6Department of Ophthalmology, Örebro University Hospital, 70185 Örebro, Sweden
7Medical Department, Novartis Sweden AB, 18311 Täby, Sweden

Received 3 August 2011; Accepted 7 September 2011

Academic Editor: G. L. Spaeth

Copyright © 2011 Lars Hjelmqvist et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

How to Cite this Article

Lars Hjelmqvist, Charlotte Lindberg, Pär Kanulf, Henrik Dahlgren, Ingrid Johansson, and Annica Siewert, “One-Year Outcomes Using Ranibizumab for Neovascular Age-Related Macular Degeneration: Results of a Prospective and Retrospective Observational Multicentre Study,” Journal of Ophthalmology, vol. 2011, Article ID 405724, 8 pages, 2011. doi:10.1155/2011/405724